Form 4: Senseonics Director Sharon Larkin Receives Significant Equity Grants

Senseonics Holdings, Inc. Director Sharon Larkin was granted 111,386 restricted stock units and 157,234 stock options as part of the company's non-employee director compensation policy.

Summary

• Senseonics Holdings, Inc. Director Sharon Larkin reported the acquisition of 111,386 shares of Common Stock in the form of Restricted Stock Units (RSUs) on May 23, 2025.
• These RSUs were granted at a price of $0 per share and represent a contingent right to receive one share of common stock per RSU.
• The RSUs are set to vest in full on the earlier of the one-year anniversary of the grant date (May 23, 2026) or the next annual stockholders meeting, contingent on continuous service.
• Additionally, Ms. Larkin was granted 157,234 stock options on May 23, 2025, with an exercise price of $0.51 per share.
• These stock options also vest in full on the earlier of the one-year anniversary of the grant date (May 23, 2026) or the next annual stockholders meeting, subject to continuous service.
• Following these transactions, Sharon Larkin beneficially owns 640,206 shares of Common Stock and 157,234 stock options.
• Both grants were made pursuant to the Issuer's non-employee director compensation policy.

Sentiment

Score: 6

Explanation: The document reports routine equity compensation for a director, which is a positive for aligning interests but not indicative of significant new operational or financial developments. It's a standard disclosure.

Positives

• The equity grants to Director Sharon Larkin align her interests with those of the shareholders, as her compensation is tied to the company's stock performance.
• The grants are part of a standard non-employee director compensation policy, indicating a structured approach to governance and incentivization.

Future Outlook

The vesting of the granted Restricted Stock Units and stock options is contingent upon the director's continuous service through the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting.

Industry Context

The granting of equity compensation, such as Restricted Stock Units and stock options, to non-employee directors is a common practice across publicly traded companies. This method is widely used to attract and retain qualified board members and to align their financial interests with the long-term performance of the company and its shareholders.

Comparison to Industry Standards

• The compensation structure involving RSUs and stock options for non-employee directors is a standard practice observed in many public companies, including those in the medical technology and healthcare sectors.
• While specific grant sizes vary by company size, industry, and individual director responsibilities, the use of equity to incentivize long-term commitment and performance is consistent with global benchmarks for corporate governance and executive compensation.

Corporate Governance

Related Party Transactions

• The grants of 111,386 Restricted Stock Units and 157,234 stock options to Sharon Larkin, a director of Senseonics Holdings, Inc., constitute related party transactions as they involve compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The equity grants align the director's financial incentives with shareholder value creation, as the value of the grants is tied to the company's stock performance.
• Employees: No direct impact on employees is indicated by this filing, though a well-governed company can indirectly benefit all stakeholders.

Next Steps

• The RSUs and stock options will vest based on the specified conditions (earlier of one-year anniversary or next annual stockholders meeting, subject to continuous service).

Key Dates

Keywords

Senseonics Holdings, SENS, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, RSU, Stock Options, Equity Grant, Corporate Governance